OptimizeRx Corporation (OPRX)

Market Cap	106.47M
Revenue (ttm)	88.18M
Net Income (ttm)	-24.17M
Shares Out	18.42M
EPS (ttm)	-1.34
PE Ratio	n/a
Forward PE	21.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,974
Open	6.25
Previous Close	6.19
Day's Range	5.78 - 6.30
52-Week Range	3.78 - 16.65
Beta	1.38
Analysts	Buy
Price Target	9.06 (+56.75%)
Earnings Date	Mar 27, 2025

About OPRX

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2006
• Employees: 136
• Stock Exchange: NASDAQ
• Ticker Symbol: OPRX
• Website: https://www.optimizerx.com

Financial Performance

In 2023, OptimizeRx's revenue was $71.52 million, an increase of 14.53% compared to the previous year's $62.45 million. Losses were -$17.57 million, 53.6% more than in 2022.

Analyst Forecast

According to 8 analysts, the average rating for OPRX stock is "Buy." The 12-month stock price forecast is $9.06, which is an increase of 56.75% from the latest price.

Price Target

$9.06

(56.75% upside)

Analyst Consensus: Buy